Category Archives: Patent

COVID-19 Patent Trade Secret

NLU Delhi’s Online Panel Discussion on ‘IP and the Pandemic’ [May 5]

by
Leave a Comment

We’re pleased to inform you that the DPIIT IPR Chair at NLU Delhi is organising an online panel discussion on ‘IP and the Pandemic’ on May 5, 2021. For details, please see the announcement below: NLU Delhi’s Online Panel Discussion on ‘IP and the Pandemic’ May 5, 2021 | 7:30 PM IST The pandemic has raised several crucial issues concerning the role of Intellectual Property (IP) in the context of innovation and access to Covid-19 vaccines and pharmaceuticals. India and the…


Read More »
Copyright Patent Trademark

SpicyIP Weekly Review (April 26- May 2)

by
Leave a Comment

Topical Highlight Supreme Court Weighs in on the Crisis: Vaccine Price Equity, Compulsory Licensing and Free Speech Online In this post, Adyasha analyses the recent proceedings in the suo motu case taken up by the Supreme Court regarding matters concerning the Covid-19 pandemic. She first discusses the concerns regarding the pricing of vaccines and notes that the court asked the right questions from the Central Government as to the differential pricing for the Centre and other entities, deviation from the…


Read More »
COVID-19 Drug Regulation Patent

Supreme Court Weighs in on the Crisis: Vaccine Price Equity, Compulsory Licensing and Free Speech Online

by
Leave a Comment

After being heavily criticized for taking matters into its own hands by transferring matters related to the Covid-19 crisis from High Courts, the Supreme Court had its first hearing in the suo motu case on 30th April. A three-judge bench consisting of Justices DY Chandrachud, L Nageswara Rao and Ravindra Bhat looked into a wide variety of issues such as Oxygen & Covid drugs shortage, (the lack of) equitable pricing of vaccines, protection of health workers, possibility of invoking compulsory…


Read More »
Others Patent

NLSIU Announces Thakur Foundation PhD Scholarships in Public Health & the Law

by
Leave a Comment

We’re pleased to inform you that the National Law School of India University (NLSIU), Bangalore has announced two PhD scholarships on public health and the law, supported by the Thakur Foundation. For details, please see the announcement below. NLSIU announces the Thakur Foundation PhD Scholarships in Public Health & the Law National Law School of India University is delighted to announce a new doctoral scholarship programme, the Thakur Foundation Scholarships in Public Health & the Law. The programme is supported…


Read More »
Copyright Drug Regulation Innovation Patent Privacy Trademark

SpicyIP Weekly Review (April 19 – 25)

by
Leave a Comment

Topical Highlight Compulsory License for Covid Drugs on the Table, Says Delhi High Court In this post, Swaraj discusses the recent Delhi High Court order in the case of Rakesh Malhotra v. Govt of National Capital Territory of India and Others, in light of the worsening pandemic situation in India. The Court hauled up the government on various issues regarding the response to the pandemic so far, concerning oxygen use, ramping up of testing facilities, shortage of drugs and black…


Read More »
COVID-19 Patent

A Recipe for Disaster: Export Bans, TRIPS Waiver and Hyper Nationalism

by
Leave a Comment

(Long post ahead) On 23rd April, Ned Price, a spokesperson for the US State Department, revealed that the Biden administration is not considering lifting the export bans on the necessary raw materials for the COVID-19 vaccine. This refusal comes in response to the requests (see here and here) made by the SII CEO Adar Poonawalla to get rid of the export bans and assist in ramping up the outputs of vaccines in the global market. (Side note:  Back in Feb,…


Read More »
Geographical Indication Patent

NUJS Webinar on ‘IPR& SMEs (Special Focus on Agriculture & Food Sector): Strengthening Bonds in Prime Times’ (April 25)

by
Leave a Comment

We’re pleased to inform you that DPIIT IPR Chair, NUJS is organising a  webinar on ‘IPR & SMEs (Special Focus on Agriculture & Food Sector): Strengthening Bonds in Prime Times’ on 25th April, 2021. For further details, please see the announcement below: National Webinar on ‘IPR& SMEs (Special focus on Agriculture & Food Sector): Strengthening Bonds in Prime Times’ 25th April 2021 | 4:00 PM – 6:00 PM (IST) SMEs are the backbone of the global economy. They account for around 90 percent…


Read More »
COVID-19 Patent

Compulsory License for Covid Drugs on the Table, Says Delhi High Court

by
Leave a Comment

generic pic of vaccine

Even as the pandemic situation continues to worsen in India, the Delhi High Court yesterday put out an order that hauled up the government on various issues regarding the response to the pandemic so far, oxygen use, ramping up of testing facilities, shortage of drugs and black market selling of them, bed shortages, wastage of 44 lakh vaccines(!), etc. The 11 page order by the Division Bench, consisting of Justices Vipin Sanghi and Rekha Palli, was given in the case…


Read More »
Patent Trademark

SpicyIP Weekly Review (April 12 – 18)

by
Leave a Comment

Topical Highlight Indian Govt. Permits Manufacture of Covaxin by Haffkine Institute – But Why Not Others Too? Praharsh and Swaraj consider the recent Central Government approval of Haffkine Institute for manufacturing Covaxin, on a ‘technology transfer’ basis, for a period of one year to address the vaccine shortage in the country. They highlight that the wording of the current ‘approval’ seems to indicate that the Central Government has the rights to be able to give the permission. However, it leaves…


Read More »
COVID-19 Drug Regulation Patent

Indian Govt. Permits Manufacture of Covaxin by Haffkine Institute – But Why Not Others Too?

by
2 Comments

(This post has been co-authored with Swaraj Barooah) In what seems like a  whiff of good news amidst the debacle surrounding availability of  COVID-19 vaccine in India, the Central Government has permitted the Haffkine Institute to manufacture Covaxin, on  a “technology transfer” basis, for a period of one year. This is definitely needed and hopefully will address the vaccine shortage in the country to some extent. But does this mean that the Central Government had the IP and technology transfer…


Read More »
  1. Pages:
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9
  12. 10
  13. ...
  14. 136